UPDATE: Roche to Appeal European Decision to Revoke Taq Polymerase Patent | GenomeWeb

This story has been updated from a previous version.

NEW YORK, May 31 – Roche said Thursday it would appeal the European Patent Office’s decision to revoke Roche’s patent for a number of enzymes, including Taq DNA polymerase, a staple in conducting PCR and gene sequencing.

“We will appeal this ruling because it is incorrect,” a Roche spokeswoman said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.